EUVIMEDEUVIMED entdecken
Crossref

Colon Adenocarcinoma Quantitative Proteomics Reveals Dysregulation in Key Cancer Signaling Pathways and a Candidate Protein Marker Panel

Abhilash Barpanda, Ankit Halder, Ayushi Dhote, Shashwati Parihari, Chetan Kantharia, Sanjeeva Srivastava iD

OMICS: A Journal of Integrative Biology · 2023

DOI: 10.1089/omi.2022.0169 ↗

Kurz gefasst

Fachartikel in der Zeitschrift OMICS: A Journal of Integrative Biology, 2023. Verfasst von Abhilash Barpanda und 5 weiteren Autor:innen. Beteiligte Einrichtung: Proteomics Laboratory, Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Mumbai, Maharashtra, India. Hauptthemen laut MEDLINE: Colonic Neoplasms, Colorectal Neoplasms, Adenocarcinoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) is reportedly the second leading cause of cancer death worldwide. By the end of the decade, there will likely be more than one million fatalities worldwide from this cancer, with an estimated 2.2 million additional cases. We need new ways of thinking about cancer research. One approach is to deploy systems science using quantitative proteomics to obtain postgenomic and functional insights into cancer. The present study compares the tissue proteome of CRC ( n = 10) with the matched peritumoral controls ( n = 10) in samples obtained from the Indian subcontinent. When compared with the controls, a list of 22 substantially altered protein candidates was identified, which were associated with the growth, survival, and metastasis of the tumor. A list of the unique peptides from top significant proteins, including olfactomedin-4, alanyl aminopeptidase, and grancalcin was further validated using a parallel reaction monitoring-based targeted proteomics approach. In addition, biological pathway analysis showed perturbation in key biological processes, including dysregulation in purine metabolism, MYC targets in cancer, DNA repair, and replication, and leukocyte transendothelial migration, among others. The protein panel reported herein is also shown to be dysregulated in CRC and warrants further research toward understanding pathobiology, diagnostics, and therapeutics development in CRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colonic NeoplasmsColorectal NeoplasmsAdenocarcinomaHumansProteomicsProteomeSignal TransductionBiomarkers, Tumor

Stichwörter der Autor:innen

LC-MS/MSTMTcolorectal cancerquantitative proteomics

Substanzen

ProteomeBiomarkers, Tumor

Autor:innen und Institutionen

  • Proteomics Laboratory, Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Mumbai, Maharashtra, India.
  • Center for Research in Nanotechnology and Science, Indian Institute of Technology Bombay, Mumbai, Maharashtra, India.
  • Saint Francis de Sales College, Nagpur, Maharashtra, India.
  • Department of Surgical Gastroenterology, Seth G.S. Medical College and KEM Hospital, Mumbai, Maharashtra, India.

ORCID-Profile: Sanjeeva Srivastava

Zitieren

APA

Barpanda, A., Halder, A., Dhote, A., Parihari, S., Kantharia, C., & Srivastava, S. (2023). Colon Adenocarcinoma Quantitative Proteomics Reveals Dysregulation in Key Cancer Signaling Pathways and a Candidate Protein Marker Panel. OMICS: A Journal of Integrative Biology. https://doi.org/10.1089/omi.2022.0169

Vancouver

Barpanda A, Halder A, Dhote A, Parihari S, Kantharia C, Srivastava S. Colon Adenocarcinoma Quantitative Proteomics Reveals Dysregulation in Key Cancer Signaling Pathways and a Candidate Protein Marker Panel. OMICS: A Journal of Integrative Biology. 2023. doi:10.1089/omi.2022.0169

BibTeX
@article{Barpanda2023,
  author = {Barpanda, Abhilash and Halder, Ankit and Dhote, Ayushi and Parihari, Shashwati and Kantharia, Chetan and Srivastava, Sanjeeva},
  title = {Colon Adenocarcinoma Quantitative Proteomics Reveals Dysregulation in Key Cancer Signaling Pathways and a Candidate Protein Marker Panel},
  journal = {OMICS: A Journal of Integrative Biology},
  year = {2023},
  doi = {10.1089/omi.2022.0169}
}
Kostenlos starten →